Title : Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.

Pub. Date : 2012 May 2

PMID : 22551440






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial. taxane tumor protein p53 Homo sapiens
2 INTRODUCTION: Pre-clinical data suggest p53-dependent anthracycline-induced apoptosis and p53-independent taxane activity. taxane tumor protein p53 Homo sapiens